IRIS

Human Bone Rigeneration in maxillo-facial area using an innovative medical device for Tissue engineering (BRIMAX)

CECCARELLI, GABRIELE;BENEDETTI, LAURA;BLOISE, NORA;IMBRIANI, MARCELLO;VISAI, LIVIA;CUSELLA DE ANGELIS, MARIA GABRIELLA
2014-01-01
2014
Proceedings of the 68th Congress of Italian Society of Anatomy and Histology
Medical Research, Diagnosis & Treatment contains studies of existing and developing diagnostic and therapeutic techniques, as well as specific classes of clinical intervention. Resources in this category emphasize the difference between normal and disease states, with the ultimate goal of more effective diagnosis and intervention. Specific areas of interest include pathology and histochemical analysis of tissue, clinical chemistry and biochemical analysis of medical samples, diagnostic imaging, radiology and radiation, surgical research, anesthesiology and anesthesia, transplantation, artificial tissues, and medical implants. Resources focused on the disease, diagnosis, and treatment of specific organs or physiological systems are excluded and are covered in the Medical Research: Organs & Systems category.
ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY
Sì, ma tipo non specificato
Italiano
contributo
68th meeting of the Italian Society of Anatomy and Histology
Ancona
Nazionale
ELETTRONICO
42
42
1
Bone regeneration today is one of the most important challenges for medicine and the need for this is particularly evident in the maxillo-facial area: our clinical trial will be based on a model of bone defect as in alveolar socket preservation and sinus lift augmentation, well described surgical techniques. The RIGENERA® system permits extraction of stem cells from a small sam-ple of connective tissue obtained from the patient’s lingual mucosa or from a post-extraction surgical site (where an endosseous implant may be inserted), dental pulp or dental follicle. Our project is to demonstrate the efficacy in the maxillo-facial area of an innovative clinical protocol of bone tissue engineer-ing based on a new medical device called Rigeneracons (CE certified Class I). Our clinical trial use already acquired technologies in comparation with new technologies (new selection methods, new Bio-compatible materials etc.) produced by us. Besides, we perform an in-vitro test to quantify the prolifera-tive capacity of a cellular suspension obtained after disaggregation of connec-tive tissue originating from the oral cavity using the RIGENERA® system, a biologic tissue disaggregator (Human Brain Wave–Torino, Italy) that recently came on the market. Evaluation of the histologic characteristics of neo-formed osseous tissue will be shown and discussed.
none
Ceccarelli, Gabriele; Benedetti, Laura; Bloise, Nora; Graziano, A; Imbriani, Marcello; Visai, Livia; CUSELLA DE ANGELIS, MARIA GABRIELLA
273
info:eu-repo/semantics/conferenceObject
7
4 Contributo in Atti di Convegno (Proceeding)::4.1 Contributo in Atti di convegno
4.1 Contributo in Atti di convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1197591
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact